C12N 2770/24023
Virus like particles [vlp]
Official title: Virus like particles [VLP]
C12N2770/24023 (Virus like particles [vlp]) appears on 5 US grants and 9 published applications in this corpus.
Search patents in C12N- Granted patents
- 5
- Published applications
- 9
- Assignees
- 6
- Inventors
- 16
- Latest grant
- 19 Jul 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 1 |
| 2016 | 0 | 1 |
| 2017 | 1 | 0 |
| 2018 | 2 | 2 |
| 2019 | 0 | 1 |
| 2020 | 1 | 1 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
| 2023 | 0 | 2 |
| 2024 | 0 | 1 |
By publication year.
Recent patents
- Flavivirus and alpha virus virus-like particles (VLPS)19 Jul 2022US 11,389,522 B2TechnoVax, Inc.
- Flavivirus and alphavirus virus-like particles (VLPS)13 Oct 2020US 10,799,575 B2TechnoVax, Inc.
- Chimeric dengue virus E glycoproteins comprising mutant domain I and domain II hinge regions6 Nov 2018US 10,117,924 B2The University of North Carolina at Chapel Hill
- Flavivirus virus like particle16 Oct 2018US 10,098,943 B2VLP Therapeutics, LLC
- Chimeric dengue virus E glycoproteins comprising mutant domain I and domain II hinge regions21 Nov 2017US 9,821,050 B2The University of North Carolina at Chapel Hill
- Bacteriophage virus-like particle vaccines against flavivirus non-structural protein 126 Sep 2024US 2024/0316174 A1UNM Rainforest Innovations
- Compositions and methods for reducing uric acid concentration using nanocapsule-based drug delivery system21 Sep 2023US 2023/0293641 A1VL Biotech Inc.
- Compositions and methods for controlling blood sugar levels using nanocapsule-based drug delivery system21 Sep 2023US 2023/0295640 A1VL Biotech Inc.
- Flavivirus and alphavirus virus-like particles (vlps)24 Dec 2020US 2020/0397887 A1TechnoVax, Inc.
- Chimeric dengue virus e glycoproteins comprising mutant domain i and domain ii hinge regions22 Aug 2019US 2019/0255168 A1The University of North Carolina at Chapel Hill
Most cited
By later US patents
- Flavivirus virus like particle6US 10,098,943 B2VLP Therapeutics, LLC · 2018
- Chimeric dengue virus E glycoproteins comprising mutant domain I and domain II hinge regions1US 10,117,924 B2The University of North Carolina at Chapel Hill · 2018
- Chimeric dengue virus E glycoproteins comprising mutant domain I and domain II hinge regions1US 9,821,050 B2The University of North Carolina at Chapel Hill · 2017